C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,630 | -46.8% | 25,997 | +0.0% | 0.00% | – |
| Q4 2022 | $153,335 | -27.3% | 25,989 | +8.2% | 0.00% | – |
| Q3 2022 | $211,000 | +139.8% | 24,030 | +106.0% | 0.00% | – |
| Q2 2022 | $88,000 | -63.3% | 11,664 | +17.5% | 0.00% | – |
| Q1 2022 | $240,000 | -19.5% | 9,924 | +6.8% | 0.00% | – |
| Q4 2021 | $298,000 | -21.6% | 9,288 | +8.9% | 0.00% | – |
| Q3 2021 | $380,000 | +17.3% | 8,530 | -0.7% | 0.00% | – |
| Q2 2021 | $324,000 | – | 8,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $21,495,000 | 5.67% |
| Soleus Capital Management, L.P. | 750,633 | $33,538,000 | 5.23% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $73,374,000 | 4.55% |
| RTW INVESTMENTS, LP | 2,494,965 | $111,475,000 | 1.68% |
| P.A.W. CAPITAL CORP | 40,000 | $1,787,000 | 1.59% |
| Perceptive Advisors | 2,258,566 | $100,913,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 381,774 | $17,058,000 | 1.43% |
| CLOUGH CAPITAL PARTNERS L P | 347,500 | $15,526,000 | 0.94% |
| HighVista Strategies LLC | 29,341 | $1,311,000 | 0.87% |
| RA Capital Management | 1,377,569 | $61,550,000 | 0.85% |